»Jane Plumb

About Jane Plumb

This author has not yet filled in any details.
So far Jane Plumb has created 58 blog entries.

Test in development for sepsis

A new test has been developed to detect sepsis earlier by researchers at Strathclyde University. Currently, tests for sepsis usually takes at least 12 and up to 72 hours, whereas the new test could take as little as less than 3 minutes. It is hoped the new test could be available on the NHS in 3-5 years. You can read the Sky News report here, and the medical paper here. “Detecting sepsis so much earlier is vital - early detection means early treatment with appropriate medicine. And that will save lives. This is real progress and we look forward to learning more."

By |2019-02-20T18:59:02+00:00February 19th, 2019|Latest News|0 Comments

New Group B Strep (GBS) Online Course available

Group B Strep Support and Microbirth School are delighted to launch our new online course to help midwives and doctors better understand and prevent group B Strep infection in babies. Group B Strep is a common bacterium carried by many adults in the gut and in women in the vagina, usually causing no harm. However, it the most common cause of severe infection in newborn babies, and of meningitis in babies during their first 3 months of life. Group B Strep causes sepsis, pneumonia and meningitis. If left untreated, the infection can kill a newborn baby in hours. On average in the UK: two babies each day develop a group B Strep infection one baby each week dies from [...]

By |2019-02-20T18:40:30+00:00February 5th, 2019|Latest News|0 Comments

New funding towards developing a group B Strep vaccine

Today MinervaX, a privately held Danish biotech company, announced that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to combat antimicrobial resistance (AMR). An additional investment of 0.8 mEUR was obtained from SunStone Capital. The funding will be used to help finalise Phase I development of the company’s protein-only GBS vaccine, targeting pregnant women for the prevention of life-threatening infections in newborns. Jane Plumb MBE, Group B Strep Support's Chief Executive, said: "We welcome the news that MinervaX’s Phase 1 program of their group B Strep vaccine will be finalised thanks to funding from the REPAIR Impact Fund. Group B Strep is the most common cause of [...]

By |2019-01-21T16:45:37+00:00January 21st, 2019|Latest News|0 Comments

NHS Long Term Plan

Group B Strep Support welcomes the Government’s publication of a Long Term Plan for the NHS, and the increased funding of £20.6bn by 2023/4. The Government aims to achieve 50% reductions in stillbirth, maternal mortality, neonatal mortality and serious brain injury by 2025, including the rolling out of the Saving Babies Lives Care Bundle throughout England in 2019 and an increased focus on preventing preterm birth. We encourage this ambition, and believe it is crucial that group B Strep prevention is improved as part of meeting this target. We welcome the working with midwives, mothers and their families to implement continuity of carer so that, by March 2021, most women receive continuity of the person caring for them during [...]

By |2019-01-07T18:00:31+00:00January 7th, 2019|Latest News|0 Comments

Group B Strep Support responds to Each Baby Counts 2018 Progress Report

The Royal College of Obstetricians and Gynaecologists (RCOG) today released their Each Baby Counts 2018 progress report, which is intended to improve maternity care and reduce potentially avoidable deaths and serious harm to babies during birth and in their first seven days. The report found that different care might have led to a different outcome in almost three quarters of stillbirths, neonatal deaths and severe brain injuries included in the review. Worryingly, in almost half (45%) of the affected babies, guidelines and best practice were not followed. Reasons for this included gaps in training, lack of recognition of problems, and local guidelines not being based on best available evidence. There has been an increase in parents invited to be [...]

By |2018-11-13T13:57:26+00:00November 13th, 2018|Latest News|0 Comments

Baby Loss Awareness Week 2018

Every year in the UK, thousands of people are affected by the death of a baby or experience pregnancy loss. A collaboration between more than 60 charities across the UK, Baby Loss Awareness Week is held from 9 to 15 October to raise awareness about the key issues affecting those who have experienced pregnancy loss or baby death in the UK. Throughout the week bereaved parents, their families and friends, unite with each other and others across the world to commemorate the lives of babies who died during pregnancy, at or soon after birth and in infancy. Now in its 16th year, Baby Loss Awareness Week calls for tangible improvements in research, care and policy around bereavement support and [...]

By |2018-10-11T08:58:21+00:00October 9th, 2018|Latest News|0 Comments

RCM Conference 2018

We're just back from the Royal College of Midwives' Annual Conference. We had a table in the Charity Area of the exhibition and, from the moment the doors opened on Thursday morning, were inundated with midwives and student  midwives keen to get the most up to date information about group B Strep. Thousands of our latest leaflet, "Group B Streptococcus (GBS) in pregnancy and newborn babies" were taken, and a similar number of our summary of the latest GBS guidelines. Hundreds of pens and GBS ALERT stickers made their way into midwives' bags, together with order forms to be taken away and filled in at a later date. There were some great conversations! It was also good to catch [...]

By |2018-10-17T08:05:51+00:00October 8th, 2018|Latest News|0 Comments

Future GBS vaccine highly likely to be cost-effective at preventing life-threatening infections in babies

Group B Strep bacteria which one in every 4 to 5 pregnant women carry, and which can cause death or serious complications in their babies, could be targeted in a cost-effective way by a future vaccine – even if it costs the NHS as much as £54 a dose. Group B Strep (GBS) infection, caused by Group B Streptococcus, is the most common cause of life-threatening infection in newborn babies, and of meningitis in infants up to age 5. On average in the UK, two babies a day develop group B Strep infection, one baby a week dies from their GBS infection and another baby every week survives with long-term health issues. The UK’s current group B Strep prevention [...]

By |2018-11-16T14:46:01+00:00October 4th, 2018|Latest News|0 Comments

Survey into long-term impacts of late-onset group B Strep infection in babies

Group B Strep Support is the only UK charity dedicated to eradicating group B Strep (GBS) infections, including meningitis, in babies. We provide up-to-date, evidence-based information on GBS to families and health professionals, and support affected families. We are seeking better to understand the long-term consequences of late-onset group B Strep infection (occurring at age 7+ days), both for the infected baby and the family, and are inviting parents of babies who developed late-onset GBS infection to take part in a survey. We will use the findings to inform our work to influence UK policy and practice, to prevent early-onset GBS infection. If you have had a baby who developed late-onset group B Strep infection, we invite you to [...]

By |2018-09-06T17:12:41+00:00August 14th, 2018|Latest News|0 Comments

July is Group B Strep Awareness Month #GBSAM18

July is Group B Strep Awareness Month and charity Group B Strep Support is asking everyone to raise awareness during the month, using the hashtag #GBSAM18. Group B Strep is the most common cause of life-threatening infection in newborn babies in the UK, and the most common cause of meningitis in babies under age 3 months. And the number of these infections are rising. Currently: 2 babies a day develop group B Strep infection 1 baby a week dies from group B Strep infection 1 baby a week recovers from group B Strep infection with disability 319,000 babies are estimated to have developed GBS infection aged 0-90 days worldwide in 2015, with approximately 4.1 infections in every 1,000 liveborn [...]

By |2018-06-20T11:31:26+00:00June 20th, 2018|Latest News|0 Comments